Enxidipine Price Revealed: How much does a bottle cost?

Enasidenib is a targeted therapy for adult patients with relapsed or refractory acute myeloid leukemia (AML) harboring isocitrate dehydrogenase-2 (IDH2) mutations. Although the drug has been approved and used clinically in the international market, as of April 2025, ensidipine has not yet been launched in the Chinese market and therefore cannot be included in medical insurance. This places a high financial burden on many patients who need this medication.

In overseas markets, the price of the original drug of ensidipine is generally higher. For example, the common specifications of boxes of 50 mg 30 tablets and 100 mg 30 tablets generally cost more than 300,000 yuan, which is a heavy burden for most patients. In addition, due to factors such as exchange rate fluctuations, the actual selling price of drugs may fluctuate, causing patients to face additional uncertainty when obtaining drugs.

However, with the increase in market demand, some pharmaceutical companies have begun to produce generic drugs of ensidipine, which provides patients with a more economical choice. For example, a generic drug of 50mg*30 tablets produced by a pharmaceutical factory in Laos may be sold for only more than 1,000 yuan. This price is significantly lower than that of the original drug, making this treatment affordable for more patients. Importantly, the ingredients of these generic drugs are basically the same as those of foreign original drugs and can provide patients with similar curative effects.

Although the original drug of ensidipine has not yet been launched in China, with the continuous innovation of AML treatment options around the world, the market has gradually increased its attention to this drug. In the future, if ensidipine can successfully enter the Chinese market and be priced appropriately according to the needs of domestic patients, it may bring new hope to more patients with acute myeloid leukemia suffering from IDH2 mutations.

Reference materials:https://www.idhifa.com/